Denise C Vidot1,2, Jessica Y Islam3, Melissa B Harrell4, Devika R Rao5, Jennifer V Chavez1, WayWay M Hlaing2, Michelle Weiner6, Sarah E Messiah7,8. 1. School of Nursing and Health Studies, University of Miami, Coral Gables, FL, USA. 2. Miller School of Medicine, University of Miami, Miami, FL, USA. 3. Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 4. UTHealth, School of Public Health, Austin Campus, TX, USA. 5. Division of Respiratory Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA. 6. College of Osteopathic Medicine, Nova Southeastern University, Davie, FL, USA. 7. University of Texas Health Science Center School of Public Health, Dallas Campus, Dallas, TX, USA. 8. Center for Pediatric Population Health, UT Health School of Public Health and Children's Health System of Texas, Dallas, TX, USA.
Abstract
Background: Clinical indications for medicinal cannabis include chronic conditions; thus users (MCUs) are at an increased risk of morbidity and mortality resulting from SARS-CoV-2 infection (COVID-19). The study aimed to provide data on cannabis use and self-reported behavioral changes among MCUs with preexisting chronic conditions in response to the pandemic. Methods: An internet-based questionnaire was administered to adults ≥18 who self-reported medicinal cannabis use within the past year. Data are from respondents between March 21 and April 23, 2020; response rate was 83.3%. Health conditions and cannabis frequency, route, and patterns of use were assessed via the COVID-19 Cannabis Health Questionnaire (Vidot et al. 2020). Results: Participants (N = 1202) were predominantly non-Hispanic white (82.5%) and 52.0% male (mean age 47.2 years). Mental health (76.7%), pain (43.7%), cardiometabolic (32.9%), respiratory (16.8%), and autoimmune (12.2%) conditions were most reported. Those with mental health conditions reported increased medicinal cannabis use by 91% since COVID-19 was declared a pandemic compared to those with no mental health conditions (adjusted odds ratio: 1.91, 95% CI: 1.38-2.65). 6.8% reported suspected COVID-19 symptoms. Two percent (2.1%) have been tested for COVID-19 with only 1 positive test result. Some MCUs (16%) changed their route of cannabis administration, switching to nonsmoking forms.Conclusions: The majority of MCUs reported at least one preexisting chronic health condition. Over half report fear of COVID-19 diagnosis and giving the virus to someone else; yet only some switched from smoking to nonsmoking forms of cannabis. Clinicians may consider asking about cannabis use among their patients, particularly those with chronic health conditions.
Background: Clinical indications for medicinal cannabis include chronic conditions; thus users (MCUs) are at an increased risk of morbidity and mortality resulting from SARS-CoV-2 infection (COVID-19). The study aimed to provide data on cannabis use and self-reported behavioral changes among MCUs with preexisting chronic conditions in response to the pandemic. Methods: An internet-based questionnaire was administered to adults ≥18 who self-reported medicinal cannabis use within the past year. Data are from respondents between March 21 and April 23, 2020; response rate was 83.3%. Health conditions and cannabis frequency, route, and patterns of use were assessed via the COVID-19 Cannabis Health Questionnaire (Vidot et al. 2020). Results: Participants (N = 1202) were predominantly non-Hispanic white (82.5%) and 52.0% male (mean age 47.2 years). Mental health (76.7%), pain (43.7%), cardiometabolic (32.9%), respiratory (16.8%), and autoimmune (12.2%) conditions were most reported. Those with mental health conditions reported increased medicinal cannabis use by 91% since COVID-19 was declared a pandemic compared to those with no mental health conditions (adjusted odds ratio: 1.91, 95% CI: 1.38-2.65). 6.8% reported suspected COVID-19 symptoms. Two percent (2.1%) have been tested for COVID-19 with only 1 positive test result. Some MCUs (16%) changed their route of cannabis administration, switching to nonsmoking forms.Conclusions: The majority of MCUs reported at least one preexisting chronic health condition. Over half report fear of COVID-19 diagnosis and giving the virus to someone else; yet only some switched from smoking to nonsmoking forms of cannabis. Clinicians may consider asking about cannabis use among their patients, particularly those with chronic health conditions.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Dean G Kilpatrick; Kenneth J Ruggiero; Ron Acierno; Benjamin E Saunders; Heidi S Resnick; Connie L Best Journal: J Consult Clin Psychol Date: 2003-08
Authors: Yan Wang; Gladys E Ibañez; Krishna Vaddiparti; Nichole E Stetten; Ruba Sajdeya; Eric C Porges; Ronald A Cohen; Robert L Cook Journal: Drug Alcohol Depend Date: 2021-05-21 Impact factor: 4.852
Authors: Savannah G Brenneke; Courtney D Nordeck; Kira E Riehm; Ian Schmid; Kayla N Tormohlen; Emily J Smail; Renee M Johnson; Luther G Kalb; Elizabeth A Stuart; Johannes Thrul Journal: Int J Drug Policy Date: 2021-10-29